New member: Glaxo Smith Kline
Find out how Glaxo Smith Kline (GSK), the latest pharmaceutical cluster to enter into our ecosystem, is contributing to the oncology field.
Sofia Lindén is responsible for producing the content for digital communications in the cluster, including articles, photographs and videos for the websites and social media platforms.
She has previously worked at the Nordic publishing company Orage as Swedish Print Editor and Digital Project Manager. She also holds a master degree in International Journalism from City University London. Find out more about Sofia by visiting her LinkedIn.
Find out how Glaxo Smith Kline (GSK), the latest pharmaceutical cluster to enter into our ecosystem, is contributing to the oncology field.
Find out why a company specialising in seafood and marine ingredients has become a member of an oncology cluster.
Three leading Norwegian health innovation clusters will collaborate on forming a concept for the first Norwegian Health Catapult Centre.
Our member Link Medical has expanded its organisation with an office in London.
Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines.
We are a national non-profit member organization with about 90 members. Our members are Norwegian and international companies, research and financial institutions, university hospitals and organizations – all working in the cancer field.